Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Assessment of the depth of myometrial invasion in stage I endometrioid endometrial cancer using pancytokeratin immunohistochemistry.

Alexander-Sefre F, Singh N, Ayhan A, Thomas JM, Jacobs IJ.

Int J Gynecol Cancer. 2004 Jul-Aug;14(4):665-72.

PMID:
15304163
2.

Endometrial giant cell carcinoma: a case series and review of the spectrum of endometrial neoplasms containing giant cells.

Mulligan AM, Plotkin A, Rouzbahman M, Soslow RA, Gilks CB, Clarke BA.

Am J Surg Pathol. 2010 Aug;34(8):1132-8. doi: 10.1097/PAS.0b013e3181e6579c. Review.

PMID:
20588176
3.

Peritumorous lymph-vascular invasion, grade of histologic differentiation, and myometrial infiltration as prognostic factors of endometrial carcinoma.

De Góis NM, Martins NV, Abrão FS, De Lima GR, Alves AC.

Rev Paul Med. 1993 May-Jun;111(3):385-90. Review.

PMID:
8108630
4.

[Endometrial carcinoma--stage I. Evaluation of risk and prognostic factors in an analysis of 120 cases].

Romano FM, Bruno G, Manicastri AM.

Minerva Ginecol. 1991 Mar;43(3):97-104. Review. Italian.

PMID:
2057108
5.

Patterns of myoinvasion in endometrial adenocarcinoma: recognition and implications.

Cole AJ, Quick CM.

Adv Anat Pathol. 2013 May;20(3):141-7. doi: 10.1097/PAP.0b013e31828d17cc. Review.

PMID:
23574770
6.

Clinical aspects of risk in women with endometrial carcinoma.

Burke TW, Fowler WC Jr, Morrow CP.

J Cell Biochem Suppl. 1995;23:131-6. Review.

PMID:
8747387
7.

[Clinico-pathological staging of endometrial carcinoma and the evaluation of methods for assessing myometrial invasion in clinical stage I cases].

Liu BN, Dia ZY.

Zhonghua Fu Chan Ke Za Zhi. 1993 Jul;28(7):429-31. Review. Chinese. No abstract available.

PMID:
8287728
8.

Strategies in the histologic diagnosis of low-grade glandular endometrial neoplasm.

Izadi-Mood N, Sarmadi S, Sanii S.

Curr Opin Obstet Gynecol. 2010 Feb;22(1):43-50. doi: 10.1097/GCO.0b013e328332d0ff. Review.

PMID:
19904204
9.

Carcinoma of the cervix with extensive endometrial and myometrial involvement.

de Jesus M, Tang W, Sadjadi M, Belmonte AH, Poon TP.

Gynecol Oncol. 1990 Feb;36(2):263-70. Review.

PMID:
2404840
10.

Tumor progression, metastasis, and modulators of epithelial-mesenchymal transition in endometrioid endometrial carcinoma: an update.

Makker A, Goel MM.

Endocr Relat Cancer. 2016 Feb;23(2):R85-R111. doi: 10.1530/ERC-15-0218. Epub 2015 Nov 4. Review.

11.

[Diffuse myometrial hypertrophy. Cause of abnormal uterine bleeding. Clinico-pathological study of 4 cases and review of the literature].

Mendoza Ramón HC, Ortíz Hidalgo C.

Ginecol Obstet Mex. 1999 Aug;67:370-3. Review. Spanish.

PMID:
10504789
12.

Recent developments in multiplexing techniques for immunohistochemistry.

Dixon AR, Bathany C, Tsuei M, White J, Barald KF, Takayama S.

Expert Rev Mol Diagn. 2015;15(9):1171-86. doi: 10.1586/14737159.2015.1069182. Epub 2015 Aug 6. Review.

Supplemental Content

Support Center